Navigation Links
goal in Biological Technology

2009: Immunotec announces important clinical research initiative: New study to be launched with the goal of improving the quality of the aging process

Immunotec Receives NHPD/Health Canada Authorization to Begin a Study on the Effect of the Cysteine-Rich Whey Protein Isolate (Immunocal(R)) in Combination with Physical Exercise on Muscle Function, Body Composition and Inflammatory Cytokine Levels in Elderly Persons: A Randomized,...

BioSyntech Achieves Enrolment Goal for Pivotal Trial of BST-CarGel(R), its Cartilage Repair Device

LAVAL, QC, Feb. 2 /PRNewswire-FirstCall/ - BioSyntech, Inc. (TSX: BSY), a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced that it has completed enrolment for the Canadian-European pivotal trial of its cartilage repair device, BST-CarGel(R). The...

SHARE Program Launched to Address the Challenges of Achieving Blood Pressure Goal

MUNICH, May 15 /PRNewswire/ -- - Investigating the Real Burden of Hypertension, Addressing the Challenges of Getting to Blood Pressure Goal and SHARE(ing) the Knowledge ( http://www.SHARE-hypertension.com ) The SHARE steering committee announce the launch of Supporting Hypertensi...

Credit-card-sized platform for volatile compound analysis CAREER project goal

Blacksburg, Va. Developing a credit-card-sized gas chromatography platform that can analyze volatile compounds within seconds is the next step for Virginia Tech College of Engineering researcher Masoud Agah, who has received a National Science Foundation (NSF) Faculty Early Career Development Pro...

Software to aid brain surgery is goal of Milwaukee startup

Milwaukee, Wis. The invention of three Medical College of Wisconsin radiology professors could help doctors look inside patients' brains. Kyron Clinical Imaging Inc. received FDA clearance last week to market the software it's developing, the Milwaukee Journal-Sentinel reported . Kyron's sof...

Economic collaboration in Denver sets tall goal for Wisconsin

Shortly after he was elected mayor of Colorados largest city, businessman John Hickenlooper invited all 31 suburban mayors to a victory party. The goal was to ceremoniously bury the hatchet of intra-regional rivalry and to make it clear that Denver would prosper as a metropolitan area, or not at ...

Diversity still an elusive goal in IT, other tech fields

Former Harvard president Lawrence H. Summers created a firestorm last year when he suggested that female under-representation in math and science fields might be the result of intrinsic aptitude differences between men and women. While that comment may be only part of the reason Summers is the form...

Building the modern public-purpose university' should be UW System's goal

While there's no shortage of public chatter about University of Wisconsin administrators taking sick leave or how much the football coaches are paid, there's rarely much talk about the core 21st century challenge facing the UW System in fact, all of public higher education in America: Are our pu...

Avolte Venture Partners reaches capital goal

Madison, Wis. - Avolte Venture Partners Midwest, a venture capital arm of Boston's Peak Ridge Capital Group, Inc. , says it has reached its initial goal for raising capital and is ready to scout for early-stage investments in Wisconsin and the Midwest. The fund, which was to be capped at $50 ...

Transposagen Creates a Rat Model of the Human Immune System

...ty of mobile DNA technologies. Knockout rats are pharmaceutical research models with single gene disruptions that mimic human diseases. Transposagen's goal is to produce 30,000 unique knockout rat lines to represent each gene in the rat genome. Transposagen is also creating a cryo-preserved sperm reposito...

Oncothyreon announces webcast of second quarter 2009 financial results conference call

... Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of can...

Repligen Reports First Quarter Fiscal Year 2010 Financial Results

...ed Walter C. Herlihy, President and Chief Executive Officer of Repligen Corporation. "Our financial resources will allow us to continue to pursue our goal to build a sustainable biopharmaceutical company by developing innovative products that have the potential to markedly improve patients' lives." ...

NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application

...formed at the request of the FDA. We believe that with this updated review timeline, if we gain approval in November, we may still achieve our overall goal of launching Qutenza in the United States in the first half of 2010." Conference Call Details The Company will hold its quarterly conf...

Orexigen(R) Therapeutics to Speak at Canaccord Adams Global Growth Conference

...ages of Phase 2 clinical development. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the Company can be found at www.orexigen.com . ...

Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results

... Priority Review by the FDA. The FDA has issued a goal date for the NDA of November 13, 2009 under the Pr...an experienced commercial leadership team with the goal of being prepared to launch Acetavance at the earl... product candidate in July and the resulting PDUFA goal date of November 13, 2009. With the acceleration o...

GeoVax Labs, Inc. Provides Clinical Studies Update

... To help serve those people who are already infected with HIV, the Company is preparing for a Phase 1 therapeutic trial to start in early 2010. "The goal here is to reduce the need for anti-viral drugs. This initial trial will determine the safety and immunogenicity of the vaccine in patients with well...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

...her disease. Fast Track is a process which expedites the review of drugs to treat serious diseases and fill an unmet medical need with the goal of getting important new treatments to patients earlier. Shire will file additional sections of the NDA as they become available. Results ...

New angle on gecko research

...asic research assist them in designing experiments through an appreciation of how evolution has crafted its own solutions to complex problems. The goal of Russell's research is to try to understand this complex traction system and to apply this knowledge to the development of commercial applications. ...

Plastics that convert light to electricity could have a big impact

...liably form the proper structure at the nanoscale (tinier than 2-millionths of an inch) to be highly efficient in converting light to electricity. The goal is to develop cells made from low-cost plastics that will transform at least 10 percent of the sunlight that they absorb into usable electricity and c...

Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update

... remain on track to report results from our pivotal Phase 3 SPEAR trial of picoplatin in small cell lung cancer in the fourth quarter of 2009 with the goal of commercializing picoplatin in 2010." Recent Clinical and Corporate Developments Picoplatin Clinical Developments Card...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

...ecutive Officer of Senomyx. "Our primary business goal is to maximize the revenue potential of our flavor...r. - Sweet Enhancer Program: The primary goal for this program is to identify flavor ingredients...s are ongoing. - Salt Enhancer Program: The goal of the Salt Enhancer Program is to identify flavor...

Oncothyreon appoints Diana Hausman as Vice President of Clinical Development

... Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of can...

SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY, DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS

...r, President and Chief Executive Officer of the Company. "We believe there is a large market opportunity for these flavor ingredients, and it is a key goal for Senomyx to have our Sweet Enhancers introduced into the marketplace as quickly, broadly and efficiently as possible. "Firmenich is a glob...

Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer

... Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of can...

Yongye International Announces Branded Store Network Increases Over 40% to 5,000 Stores

...s penetration into the farming communities while also pulling product through the channel," said Mr. Zishen Wu, CEO of Yongye International, Inc. "Our goal is to get the product into the hands of more and more farmers so they can benefit from the use of Shengmingsu and we are accomplishing this. We are co...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

...(R)) in the United States provides a foundation for achieving our long-term goal of becoming a fully integrated specialty pharmaceutical company and creatin...rough use of Intermezzo ((R)); and the ability of Transcept to achieve its goal of becoming a fully integrated specialty pharmaceutical company. Transcept ...

TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction

...nts with better alternatives to existing therapies through the research, development and commercialization of small molecule compounds. The company's goal has been to develop versatile product candidates each capable of treating a number of acute and chronic diseases and disorders such as migraine and ch...

Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing

...ther advance its multiple myeloma research and development program with the goal of initiating a Phase I clinical trial. "We are excited by the pot...veral weeks ago, enables us to continue moving forward efficiently with our goal of filing an Investigational New Drug Application and initiating a Phase I ...

IIVS Announces Initiation by EPA of a Pilot Program to Evaluate Non-Animal Eye-Irritation Methods

...ership gives to in vitro methods and hope that this will lead to EPA guidelines that will more permanently cover this type of approach." The goal of the EPA's pilot program is to evaluate the effectiveness of a non-animal testing method to replace the current Draize rabbit eye test. This approxi...

Osteotech Resumes Shipments of Bulgarian Tissue

...as a result of product contamination or deficiencies in the tissue grafts," said Greg Cannedy, Vice President of Regulatory Affairs at Osteotech. "Our goal was to resolve the deficiencies cited in the afssaps audit report as soon as possible. With this decision by afssaps we continue to build upon our exc...

RadMD First to Offer CME-Certified Education and Training For Medical Imaging in Clinical Trials

... "A huge number of clinical trials use medical imaging to demonstrate effectiveness," said Lisa Schleelein, MEd, ICPME's director of CME. "The primary goal of CME activities is to improve practice performance and patient care. RadMD is contributing to the overall quality of this process with educational a...

United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients

...to the groin of a patient who is suffering from heart failure, the cells are injected into the scar tissue that has formed in the patient's heart. The goal of MyoCell SDF-1 is to grow new contractile muscle within the scar tissue that will have the ability to release additional beneficial proteins to assi...

Cynosure Reports Second Quarter 2009 Financial Results

...his year," Davin said. "We remain on track to achieve our previously stated goal of annualized operating expense savings of between $14 million and $18 mill...2009," Davin said. "We continue to carefully manage our business, with the goal to be cash flow neutral for the year. In addition, we are excited about ou...

FluMist(R) Begins Shipping for 2009-2010 Influenza Season

...th Women's Professional Soccer (WPS) for "Don't Play with the Flu"(TM) ( www.dontplaywiththeflu.com ), a national health awareness campaign with the goal of increasing seasonal flu vaccination rates among eligible kids and families across the country. As part of the multi-faceted campaign, FluMist has ...

Charging ahead: University of Houston team revealing secrets of electricity-producing materials

...h amplify and provoke that potential in materials known as piezoelectrics, which naturally produce electricity when literally subjected to strain. The goal is to use piezoelectrics to create nanodevices that can power electronics, such as cell phones, MP3 players and even biomedical implants. "Nanode...

Histogen Hair Regrowth Clinical Trial Presented at ISHRS Annual Meeting

...spread condition. "Hair restoration treatments range in effectiveness and invasiveness. All of the current treatment options share the common goal of saving and redistributing existing hairs," said Dr. Craig Ziering. "For the millions of men and women who grapple every day with their ha...

Orexigen(R) Therapeutics Announces Full Exercise of Overallotment Option by Underwriters

... expected in the second half of 2009. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss, through combination therapeutic approaches. Further information about the Company can be...

QRxPharma Initiates Comparative Phase 2 Proof-of-Concept Study for MoxDuo(TM) IV Pain Therapy

...ther clinical trials leading to submission of an NDA to the US Food and Drug Administration (FDA) within the next three years. "QRxPharma's goal is to bring to market complementary analgesic options for pain specialists, delivering greater patient tolerability and efficacy than current standard...

Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration

...dard treatments include educational approaches, psychological, or behavioral modification, and medication. SHIRE PLC Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business...

Quantros ACE Helps East Jefferson General Hospital Achieve Best-in-Class Performance

.... A new case study details how Quantros ACE ™ has helped EJGH, a state-of-the-art, 454-bed facility located in Metairie, LA, move closer to its goal of achieving best-in-class performance in every department. "EJGH has achieved broader staff engagement and gained access to robust reporting ...
Other Tags
(Date:12/11/2014)... 2014  That blood pressure plays a role in human ... the medical term for high blood pressure – was first ... inflatable cuff that,s used in measuring blood pressure was invented ... new about hypertension, its triggers and its effects. In fact, ... and the best ways to treat it. For ...
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ... accuracy is the ultimate driver in long-term mass consumer ...
(Date:12/10/2014)... , Dec. 08, 2014 Research and ... the addition of the "Biometrics Market in ... http://photos.prnewswire.com/prnh/20130307/600769 ... projects such as rural banking and upgradation of ... trends witnessed in the market. Besides the aforementioned ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
Other Contents